<DOC>
	<DOCNO>NCT01666275</DOCNO>
	<brief_summary>Metabolomics study metabolic pathway unique biochemical molecule result regulatory response physiological stressor , disease process , drug therapy . By measure change metabolite concentration , range biochemical effect therapeutic intervention determine . Aspirin exacerbate respiratory disease ( AERD ) chronic inflammatory disease characterize chronic rhinosinusitis , nasal polyposis , asthma , airway reactivity aspirin and/or nonsteroidal anti-inflammatory drug ( NSAIDs ) . This reaction aspirin challenge/desensitization equivalent allergic drug reaction however able evaluate specific reaction control , clinical environment . This population patient undergo aspirin desensitization ideal study metabolomics serial blood sampling perform patient , reaction , aspirin desensitization , thereby allow patient serve biological control . The investigator hop study metabolomics allow good method identify anaphylaxis future .</brief_summary>
	<brief_title>The Metabolomics Anaphylaxis</brief_title>
	<detailed_description />
	<mesh_term>Anaphylaxis</mesh_term>
	<criteria>Patients age 1875 history aspirin anaphylaxis history hypersensitivity reaction aspirin refer clinically indicated outpatient inpatient aspirin desensitization procedure AERD . Pregnancy/breastfeeding , possibility poor compliance , unwilling undergo aspirin desensitization .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>